HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

DTS-108

a peptidic prodrug of SN38/irinotecan, developed to bypass hepatic activation and reduce the gastrointestinal toxicity and interpatient variability compared with irinotecan; structure in first source
Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results